4(-3-(-2-(phenyl)morpholino)-2-oxopyrro lidin1-yl)-n-(thiazol-2-yl)benzenesulfonamid e derivati ves and related compounds as modulators of ion channels for the treatment of pain

Details for Australian Patent Application No. 2008321137 (hide)

Owner Vertex Pharmaceuticals Incorporated

Inventors Numa, Mehdi Michel Djamel; Zimmermann, Nicole; Neubert, Timothy; Whitney, Tara; Kawatkar, Aarti Sameer; Martinborough, Esther; Stamos, Dean

Agent Baldwins

Pub. Number AU-A-2008321137

PCT Pub. Number WO2009/064747

Priority 60/987,485 13.11.07 US; 61/088,141 12.08.08 US

Filing date 12 November 2008

Wipo publication date 22 May 2009

International Classifications

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

A61K 31/427 (2006.01) - not condensed and containing further heterocyclic rings

A61P 25/04 (2006.01) Drugs for disorders of the nervous system

Event Publications

3 June 2010 PCT application entered the National Phase

  PCT publication WO2009/064747 Priority application(s): WO2009/064747

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008321142-Heterocyclic derivatives as modulators of ion channels

2008321129-Encapsulated low viscosity hydrophobic liquid actives